You may be correct but they cover my ASX holdings and like most shares DYOR
Printable View
FWIW my broker has just come out with a buy and a $14 1 year price target.
Beagle its not a cheap shot at all. I'm merely pointing out that blindly following anyone is a dangerous game. I agree Harbour are one of the better professional managers in NZ but even they make mistakes, sometimes quite big ones so just because they love A2 doesn't make it good.
For the record I think A2 have executed amazingly well so far and I'd say the odds are that we get to $20 before it ever sees $9.00. I own some, like their prospects, and think the market over-reacted yesterday.
Today Goldman Sachs TP $13.80
Once this years results are ann Im picking that there will be the first dividend which will appeal to instos who do / cannot hold due to no divi, watch the rerating then.
Fair enough. We all make mistakes. I don't blindly follow any analyst and don't invest with them because I don't like some of their current holdings, for example FBU but I do think they've been dead right with ATM and have owned for a long time so I am more than happy to trust their analysis of the situation and accept their explanation of the repackaging affecting short term sales at face value as compared to some other fund manager trying to justify why they've never held.
12.50 by close?
Recently in HK (flew AIR) and both A2 and Illuma stocked in Mannings. They are the largest pharmaceutical chain in HK, and quite often see "Ants" in their stores - Chinese who come over the border and fill up their suitcases with product.
All around same size (900g) but in terms of price, below Illuma (not Illuma Atwoo). Mead Johnson had a lot of product there and their 'Enfinitas' brand was over $500 HKD/can.
Attachment 9675
Sorry you might have to rotate your head or computer as I can't rotate the photo.....